Related Experiment Video

Updated: Aug 8, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

New approaches for assessing the etiology and risks of developmental abnormalities from chemical exposure

L R Goldman1

  • 1Office of Prevention, Pesticides, and Toxic Substances, U.S. Environmental Protection Agency, Washington, D.C.

Reproductive Toxicology (Elmsford, N.Y.)
|March 1, 1997
PubMed

Insights

Developmental toxicants pose risks from conception through childhood, causing birth defects and long-term health issues. New research approaches are a priority to assess these environmental chemical risks, especially for children.

Area of Science:

  • Environmental Health
  • Toxicology
  • Developmental Biology

Background:

  • Developmental toxicants can cause spontaneous abortions, malformations, and long-term health issues with unknown causes.
  • There is a global priority to identify the causes and risks of developmental effects from environmental chemicals.
  • International harmonization of testing and risk assessment guidelines for developmental effects is crucial.

Purpose of the Study:

  • To address the urgent need for new approaches in assessing the etiology and risks of developmental effects.
  • To prioritize research on specific chemical classes like lead, persistent organic pollutants (POPs), and endocrine disruptors.
  • To improve quantitative risk assessment methodologies, with a focus on children's health.

Main Methods:

  • The Environmental Protection Agency (EPA) is reinventing its research agenda.
  • Involving national experts, the National Science Foundation, and other federal agencies in research efforts.
  • Focusing on public health and environmental priorities within the United States.

Main Results:

  • The abstract does not contain specific results but outlines research priorities and strategic shifts.
  • The focus is on developing new methodologies for risk assessment.
  • Prioritization of research areas including specific chemical classes and vulnerable populations.

Conclusions:

  • New research approaches are essential for understanding and mitigating risks from developmental toxicants.
  • International collaboration and harmonization are key to effective risk assessment.
  • Protecting public health, particularly children's health, from environmental chemical exposures is a critical priority.

More Related Videos

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...